November 30, 2016 / 6:15 AM / a year ago

BRIEF-Ablynx achieves first milestone in collaboration with Novo Nordisk

Nov 30 (Reuters) - Ablynx NV :

* Ablynx achieves first milestone as part of collaboration with Novo Nordisk

* Ablynx to receive 1 million euro ($1.06 million) success fee

* Ablynx received an upfront license fee of 5 million euros and will receive up to 4 million euros in research funding during the initial three year research term of the collaboration

* Ablynx is eligible to receive potential development, regulatory and commercial milestone payments of up to 182 million euros plus tiered royalties on the annual net sales Source text for Eikon: Further company coverage: ($1 = 0.9409 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below